Implementation of medication review type 2a in community pharmacies: a longitudinal survey study
Repeated surveys offer timely insights into MR2a implementation in community pharmacies. The slow progress confirms existing obstacles and stresses the importance of continued support and improved interprofessional collaborations. These insights are expected to inform MR implementation locally and internationally.
Authors
- Stéphanie Patris
- Olivia Dalleur (ORCID: https://orcid.org/0000-0002-1072-987X)
- Stéphane Steurbaut (ORCID: https://orcid.org/0000-0003-4586-6919)
- Eline Tommelein (ORCID: https://orcid.org/0000-0001-7598-6976)
- Guido R.Y. De Meyer (ORCID: https://orcid.org/0000-0003-3848-8702)
- N Duquet
- Carine De Vriese (ORCID: https://orcid.org/0000-0002-6595-1742)
- Hans De Loof (ORCID: https://orcid.org/0000-0003-4488-551X)
- Veerle Foulon (ORCID: https://orcid.org/0000-0002-4053-3915)
- Erwin Wauters (ORCID: https://orcid.org/0000-0002-1054-0487)
- Delia Mendez Santos (ORCID: https://orcid.org/0000-0002-9281-5068)
- Isabelle De Wulf
- Geneviève Philippe
- Eline Tobback
Institutions
- University of Mons (BE)
- Cliniques Universitaires Saint-Luc (BE)
- Université Libre de Bruxelles (BE)
- Vrije Universiteit Brussel (BE)
- University of Antwerp (BE)
- University of Liège (BE)
- Universitair Ziekenhuis Brussel (BE)
- Association Pharmaceutique Belge (BE)
- UCLouvain (BE)
- KU Leuven (BE)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-11-12
- DOI
- https://doi.org/10.3389/fphar.2025.1685922
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00